List of Medrio eCOA/ePRO Customers
San Francisco, 94104, CA,
United States
Since 2010, our global team of researchers has been studying Medrio eCOA/ePRO customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Medrio eCOA/ePRO for Clinical Trial Management from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Medrio eCOA/ePRO for Clinical Trial Management include: DP Clinical, a United States based Professional Services organisation with 120 employees and revenues of $15.0 million, Swing Therapeutics, a United States based Healthcare organisation with 35 employees and revenues of $5.0 million, Rose Research Center, a United States based Professional Services organisation with 11 employees and revenues of $2.0 million and many others.
Contact us if you need a completed and verified list of companies using Medrio eCOA/ePRO, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Medrio eCOA/ePRO customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
DP Clinical | Professional Services | 120 | $15M | United States | Medrio | Medrio eCOA/ePRO | Clinical Trial Management | 2016 | n/a |
In 2016 DP Clinical began leveraging Medrio eCOA/ePRO and eConsent within a Clinical Trial Management deployment to support multi-site clinical research. The deployment centered on Medrio eCOA/ePRO as the primary capture and consent application, enabling both remote and in-clinic PRO and ClinRO capture across observational and interventional studies.
The implementation included tailored ePRO builds and configured eConsent workflows to support study-specific instrument delivery and participant usability needs. Medrio eCOA/ePRO was used to instrument patient reported outcomes and clinician reported outcomes, and to generate study reporting artifacts that support clinical data management and monitoring activities.
Operational coverage focused on multi-site studies in the United States, including a 12-site spinal cord injury observational trial, and impacted clinical operations, data management, and study teams responsible for site activation and participant engagement. The configuration supported mixed-mode data collection, allowing study teams to orchestrate in-clinic visits and remote follow up under unified case report form definitions.
Medrio has been a long-term partner supporting DP Clinical since 2016, delivering standardized ePRO builds and robust reporting to streamline study delivery. Reported outcomes included improved participant usability and accelerated study timelines through reusable build templates and consolidated reporting for clinical data management.
|
 |
Rose Research Center | Professional Services | 11 | $2M | United States | Medrio | Medrio eCOA/ePRO | Clinical Trial Management | 2023 | n/a |
In 2023, Rose Research Center implemented Medrio eCOA/ePRO within its Clinical Trial Management environment as a SaaS deployment in the United States. The center transitioned from paper records to Medrio’s electronic data capture and ePRO solution to collect both in-clinic and remote patient reported outcomes, focusing the launch on clinical trial data collection and site workflow efficiencies.
Medrio eCOA/ePRO was configured to support electronic data capture workflows and patient facing outcome collection, enabling structured electronic case report forms and scheduled ePRO administration for in clinic and remote visits. Study build processes were accelerated through the SaaS configuration, with study configuration, form logic, and ePRO schedules managed inside the Medrio application to enable near real time data visibility.
Operational scope centered on site coordinators and study teams across the United States, improving site level workflows for enrollment, data entry, and monitoring. The SaaS architecture reduced manual transcription steps and centralized electronic capture, which shifted operational governance toward digital validation rules and site workflow controls.
As implemented, the Medrio eCOA/ePRO deployment reduced transcription errors and missing data and enabled faster study builds and near real time visibility into patient reported outcomes.
|
 |
Swing Therapeutics | Healthcare | 35 | $5M | United States | Medrio | Medrio eCOA/ePRO | Clinical Trial Management | 2021 | n/a |
In 2021 Swing Therapeutics implemented Medrio eCOA/ePRO within a Clinical Trial Management environment to run decentralized and hybrid fibromyalgia trials in the United States. The deployment combined Medrio eCOA/ePRO with Medrio EDC to support a randomized pilot study and centralized participant reported outcome capture for regulatory submission support.
The implementation emphasized eCOA and ePRO capabilities for remote PRO collection, using a BYOD strategy and automated reminders to drive adherence. Medrio eCOA/ePRO was configured for electronic questionnaire delivery, patient compliance tracking, and timestamped data capture, while the EDC served as the authoritative clinical data repository and linked PRO responses to subject records.
Operational scope centered on clinical trial operations and participant management for US-based fibromyalgia studies, shifting data collection workflows away from site centric visits toward remote capture. Integrations between Medrio eCOA/ePRO and Medrio EDC enabled near real time synchronization of PRO data with trial case report forms and supported centralized monitoring practices.
Governance and rollout were pilot driven, with the 2021 randomized pilot used to validate BYOD provisioning, reminder cadence, and operational handoffs between site staff and remote monitoring teams. The pilot achieved approximately 98% patient compliance and the combined Medrio eCOA/ePRO and EDC configuration supported regulatory submission activities, while reducing site burden and improving the consistency of participant reported outcomes.
|
Buyer Intent: Companies Evaluating Medrio eCOA/ePRO
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||